4-hydroxynonenal, an aldehydic product of lipid peroxidation, impairs signal transduction associated with muscarinic acetylcholine and metabotropic glutamate receptors: Possible action on Gα(q/11)

Journal of Neurochemistry

Volumn 69, Issue 2, 1997, Pages 570-580

  Blanc, Emmanuelle M ^a   Kelly, Jeremiah F ^b   Mark, Robert J ^a   Waeg, Georg ^c   Mattson, Mark P ^a,d  

^a UNIVERSITY OF KENTUCKY   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c UNIVERSITY OF GRAZ   (Austria)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; Antioxidants; Calcium homeostasis; Cerebral ischemia; Endoplasmic reticulum; Glutathione; Inositol phosphate; Phospholipase C; Stroke; Vitamin E

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 3,5 DIHYDROXYPHENYLGLYCINE; 4 HYDROXYNONENAL; ALPHA TOCOPHEROL; ALUMINUM CHLORIDE; ANTIOXIDANT; CALCIMYCIN; CARBACHOL; FLUORIDE SODIUM; GALLIC ACID PROPYL ESTER; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR AGONIST; GLUTATHIONE; GUANOSINE TRIPHOSPHATASE; INOSITOL PHOSPHATE; LACTATE DEHYDROGENASE; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; PHOSPHOLIPASE C;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN ISCHEMIA; CALCIUM HOMEOSTASIS; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; DEGENERATIVE DISEASE; EMBRYO; ENDOPLASMIC RETICULUM; ENZYME ASSAY; LIPID PEROXIDATION; NERVE CELL CULTURE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; STROKE;

ANIMALIA;

EID: 0030836707     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69020570.x     Document Type: Article

References (74)

1. Andrus P. K., Taylor B. M., Sun F. F., and Hall E. D. (1994) Effects of the lipid peroxidation inhibitor tirilazad mesylate (U-74006F) on gerbil brain eicosanoid levels following ischemia and reperfusion. Brain Res. 659, 126-132.
2. Bartus R. T., Dean R. L., Beer B., and Lippa A. S. (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 214, 408-417.
3. Behl C., Davis J. B., Lesley R., and Schubert D. (1994) Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77, 817-827.
4. Behnisch T. and Reymann K. G. (1993) Co-activation of metabotropic glutamate receptors is involved in the mechanisms of long-term potentiation maintenance in rat hippocampal CA1 neurons. Neuroscience 54, 37-47.
5. Ben-Yoseph O., Boxer P. A., and Ross B. D. (1996) Assessment of the role of the glutathione and pentose phosphate pathways in the protection of primary cerebrocortical cultures from oxidative stress. J. Neurochem. 66, 2329-2337.
6. Benzi G. and Moretti A. (1995) Are reactive oxygen species involved in Alzheimer's disease? Neurobiol. Aging 16, 661-674.
7. Berridge M. J. (1995) Inositol trisphosphate and calcium signaling. Ann. NY Acad. Sci. 766, 31-43.
8. Blanc E. M., Toborek M., Mark R. J., Hennig B., and Mattson M. P. (1997) Amyloid β-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells. J. Neurochem. 68, 1870-1881.
9. Censori B., Manara O., Agostinis C., Camerlingo M., Casto L., Galavotti B., Partziguian T., Servalli M. C., Cesana B., Belloni G., and Mamoli A. (1996) Dementia after first stroke. Stroke 27, 1205-1210.
10. Collerton D. (1986) Cholinergic function and intellectual decline in Alzheimer's disease. Neuroscience 19, 1-28.
11. Cowbum R. F., O'Neil C., Ravid R., Alafuzoff I., Winblad B., and Fowler C. J. (1992) Adenylate cyclase activity in postmortem human brain: evidence of altered G protein mediation in Alzheimer's disease. J. Neurochem. 58, 1409-1419.
12. Cristol J. P., Maggi M. F., Guerin M. C., Torreilles J., and Descomps B. (1995) Nitric oxide and lipid peroxidation. C. R. Soc. Biol. (Paris) 189, 797-809.
13. m GTPase activity in aging and Alzheimer's disease: implications for altered signal transduction. Brain Res. 664, 54-60.
14. Ebadi M., Srinivasan S. K., and Baxi M. D. (1996) Oxidative stress and antioxidant therapy in Parkinson's disease. Prog. Neurobiol. 48, 1-19.
15. Esterbauer H., Schaur R. J., and Zollner H. (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11, 81-128.
16. Evans P. (1993) Free radicals in brain metabolism and pathology. Br. Med. Bull. 49, 577-587.
17. Exton J. H. (1993) Role of G proteins in activation of phosphoinositide phospholipase C. Adv. Second Messenger Phosphoprotein Res. 28, 65-72.
18. 2 hydrolysis in Alzheimer's disease. Life Sci. 53, PL439-PL444.
19. Fisher S. K., Heacock A. M., and Agranoff B. W. (1992) Inositol lipids and signal transduction in the nervous system: an update. J. Neurochem. 58, 18-38.
20. Furukawa K., Sopher B. L., Rydel R. E., Begley J. G., Pharm D. G., Martin G. M., Fox M., and Mattson M. P. (1996) Increased activity-regulating and neuroprotective efficacy of α-secretase-derived secreted amyloid precursor protein is conferred by a C-terminal heparin-binding domain. J. Neurochem. 67, 1882-1896.
21. Goodman Y. and Mattson M. P. (1994) Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury. Exp. Neurol. 128, 1-12.
22. Goodman Y., Bruce A. J., Cheng B., and Mattson M. P. (1996) Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury and amyloid β-peptide toxicity in hippocampal neurons. J. Neurochem. 66, 1836-1844.
23. Grynkiewicz G., Poenie M., and Tsien R. Y. (1985) A new generation of calcium indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450.
24. Hall E. and Braughler J. M. (1993) Free radicals in CNS injury. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 71, 81-105.
25. Hall E. D., Braughler J. M., Yonkers P. A., Smith S. L., Linseman K. L., Means E. D., Scherch H. M., Von Voigtlander P. F., Lahti R. A., and Jacobsen E. J. (1991) U-78517F: a potent inhibitor of lipid peroxidation with activity in experimental brain injury and ischemia. J. Pharmacol. Exp. Ther. 258, 688-694.
26. Hess D. T., Lin L. H., Freeman J. A., and Norden J. J. (1994) Modification of cysteine residues with Go and other neuronal proteins by exposure to nitric oxide. Neuropharmacology 33, 1283-1292.
27. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., and Cole G. (1996) Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99-103.
28. Izquierdo I. and Medina J. H. (1995) Correlation between the pharmacology of long-term potentiation and the pharmacology of memory. Neurobiol. Learn. Mem. 63, 19-32.
29. Jope R. S. (1988) Modulation of phosphoinositide hydrolysis by NaF and aluminum in rat cortical slices. J. Neurochem. 51, 1731-1736.
30. Jope R. S. (1996) Cholinergic muscarinic receptor signaling by the phosphoinositide signal transduction system in Alzheimer's disease. Alzheimers Dis. Rev. 1, 2-14.
31. Jope R. S., Song L., and Powers R. (1994) Agonist-induced, GTP-dependent phosphoinositide hydrolysis in postmortem human brain membranes. J. Neurochem. 62, 180-186.
32. Keller J. N., Mark R. J., Bruce A. J., Blanc E. M., Rothstein J. D., Uchida K., and Mattson M. P. (1997) 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience (in press).
33. Kelly J., Furukawa K., Barger S. W., Mark R. J., Rengen M. R., Blanc E. M., Roth G. S., and Mattson M. P. (1996) Amyloid β-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. Proc. Natl. Acad. Sci. USA 93, 6753-6758.
34. Kinter M. and Roberts R. J. (1996) Glutathione consumption and glutathione peroxidase inactivation in fibroblast cell lines by 4-hydroxy-2-nonenal. Free Radic. Biol. Med. 21, 457-462.
35. Koh J. Y. and Choi D. W. (1987) Quantitative determination of glutamate-mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J. Neurosci. Methods 20, 83-90.
36. Kruman I., Bruce-Keller A. J., Bredesen D. E., Waeg G., and Mattson M. P. (1997) Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. (in press).
37. Lee R., Wurtman R., Cox A., and Nitsch R. (1995) Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors. Proc. Natl. Acad. Sci. USA 92, 8083-8087.
38. Li X., Song L., and Jope R. S. (1996) Cholinergic stimulation of AP-1 and NFκB transcription factors is differentially sensitive to oxidative stress in SH-SY5Y neuroblastoma: relationship to phosphoinositide hydrolysis. J. Neurosci. 16, 5914-5922.
39. Lovell M. A., Ehmann W. D., Butler S. M., and Markesbery W. R. (1995) Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45, 1594-1601.
40. 2+ homeostasis and cell death. J. Neurosci. 15, 6239-6249.
41. Mark R. J., Lovell M. A., Markesbery W. R., Uchida K., and Mattson M. P. (1997a) A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J. Neurochem. 68, 255-264.
42. Mark R. J., Pang Z., Geddes J. W., Uchida K., and Mattson M. P. (1997b) Amyloid β-peptide impairs glucose uptake in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J. Neurosci. 17, 1046-1054.
43. Martelli A., Canonero R., Cavanna M., Ceradelli M., and Marinari U. M. (1994) Cytotoxic and genotoxic effects of five n-alkanals in primary cultures of rat and human hepatocytes. Mutat. Res. 323, 121-126.
44. Martinez M. C., Bosch-Morell F., Raya A., Roma J., Aldasoro M., Vila J., Lluch S., and Romero F. J. (1994) 4-Hydroxynonenal, a lipid peroxidation product, induces relaxation of human cerebral arteries. J. Cereb. Blood Flow Metab. 14, 693-696.
45. Mattson M. P. (1989) Acetylcholine potentiates glutamate-induced neurodegeneration in cultured hippocampal neurons. Brain Res. 497, 402-406.
46. Mattson M. P., Cheng B., Culwell A., Esch F., Lieberburg I., and Rydel R. E. (1993) Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of β-amyloid precursor protein. Neuron 10, 243-254.
47. 2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J. Neurochem. 65, 1740-1751.
48. Mattson M. P., Barger S. W., Begley J. G., and Mark R. J. (1995b) Calcium free radicals, and excitotoxic neuronal death in primary cell culture. Methods Cell Biol. 46, 187-216.
49. Mattson M. P., Furukawa K., Bruce A. J., and Blanc E. M. (1996) Calcium homeostasis and free radical metabolism as convergence points in the pathophysiology of dementia, in Molecular Mechanisms of Dementia (Wasco W. and Tanzi R., eds), pp. 103-143. Humana Press, Totowa, New Jersey.
50. McGuinness N., Anwyl R., and Rowan M. (1991) Trans-ACPD enhances long-term potentiation in the hippocampus. Eur. J. Pharmacol. 197, 231-232.
51. Montine K. S., Olson S. J., Amarnath V., Whetsell W. O., Graham D. G., and Montine T. J. (1997) Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of ApoE4. Am. J. Pathol. 150, 437-443.
52. Mosmann T. (1983) Rapid colorimetric assay for cellular growth and survival. J. Immunol. Methods 65, 55-63.
53. Nabeshima T. and Nitta A. (1994) Memory impairment and neuronal dysfunction induced by β-amyloid protein in rats. Tohoku J. Exp. Med. 174, 241-249.
54. Nitsch R., Slack B., Wurtman R., and Growdon J. (1992) Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258, 304-307.
55. Olney J. W. (1994) New mechanisms of excitatory transmitter neurotoxicity. J. Neural Transm. Suppl. 43, 47-51.
56. Pin J. P. and Duvoisin R. (1995) The metabotropic glutamate receptors: structure and functions. Neuropharmacology 34, 1-26.
57. Ross B. M., McLaughlin M., Roberts M., Milligan G., McCulloch J., and Knowler J. T. (1993) Alterations in the activity of adenylate cyclase and high affinity GTPase in Alzheimer's disease. Brain Res. 622, 35-42.
58. Roth G. S., Joseph J. A., and Mason R. P. (1995) Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging. Trends Neurosci. 18, 203-206.
59. +-ATPase. Free Radic. Biol. Med. 20, 215-223.
60. Simonian N. A. and Coyle J. T. (1996) Oxidative stress in neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 36, 83-106.
61. Smith M. A., Sayre L. M., Monnier V. M., and Perry G. (1995) Radical AGEing in Alzheimer's disease. Trends Neurosci. 18, 172-176.
62. 2-resistant cell lines. Do aldehyde by-products of lipid peroxidation contribute to oxidative stress? Biochem. J. 267, 453-459.
63. Springer J. E., Azbill R. D., Mark R J., Begley J. G., Waeg G., and Mattson M. P. (1997) 4-Hydroxynonenal, a lipid peroxidation product, rapidly accumulates following traumatic spinal cord injury and inhibits glutamate uptake. J. Neurochem. 68, 2469-2476.
64. Strathmann M. and Simon M. I. (1990) G protein diversity: a distinct class of alpha subunits is present in vertebrates and invertebrates. Proc. Natl. Acad. Sci. USA 87, 9113-9117.
65. Subbarao K. V., Richardson J. S., and Ang L. C. (1990) Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J. Neurochem. 55, 342-345.
66. Uchida K. and Stadtman E. R. (1992) Modification of histidine residues in proteins by reaction with 4-hydroxynonenal. Proc. Natl. Acad. Sci. USA 89, 4544-4548.
67. Uchida K. and Stadtman E. R. (1993) Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. J. Biol. Chem. 268, 6388-6393.
68. Uchida K., Toyokuni S., Nishikawa K., Kawakishi S., Oda H., Hiai H., and Stadtman E. R. (1994) Michael addition-type-4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis. Biochemistry 33, 12487-12494.
69. 56Fe irradiation diminishes muscarinic, but not α1-adrenergic stimulated low-Km GTPase in rat brain. Radiat. Res. 140, 382-386.
70. Waeg G., Dimsity G., and Esterbauer H. (1996) Monoclonal antibodies for detection of 4-hydroxynonenal modified proteins. Free Radic. Res. 25, 149-159.
71. Warpman U., Alafuzoff I., and Nordberg A. (1993) Coupling of muscarinic receptors to GTP proteins in postmortem human brain - alterations in Alzheimer's disease. Neurosci. Lett. 150, 39-43.
72. Yankner B. A. (1996) Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16, 921-932.
73. Yonemori R., Yamada H., Yamaguchi T., Uemura A., and Tamura A. (1996) Spatial memory disturbance after focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 16, 973-980.
74. Zheng F. and Gallagher J. P. (1992) Metabotropic glutamate receptors are required for the induction of long-term potentiation. Neuron 9, 163-172.